Ubs Asset Management Americas Inc Xenon Pharmaceuticals Inc. Transaction History

Ubs Asset Management Americas Inc

$379 Billion
Q1 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 63,568 shares of XENE stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,568

Previous 191,852 66.87%

Holding current value

$1.96 Million

Previous $7.52 Million 71.65%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 19, 2025	SELL	$33.55 - $40.74 $4.3 Million - $5.23 Million	-128,284 Reduced 66.87%	63,568 $2.13 Million
Q4 2024 Feb 14, 2025	BUY	$38.14 - $45.74 $1.11 Million - $1.33 Million	29,169 Added 17.93%	191,852 $7.52 Million
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $7,838 - $9,539	217 Added 0.13%	162,683 $6.4 Million
Q2 2024 Aug 13, 2024	BUY	$36.25 - $43.75 $3.08 Million - $3.72 Million	84,982 Added 109.68%	162,466 $6.33 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $249,202 - $403,412	8,683 Added 12.62%	77,484 $3.57 Million
Q3 2023 Nov 13, 2023	BUY	$34.16 - $39.73 $537,985 - $625,707	15,749 Added 29.69%	68,801 $2.35 Million
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $472,254 - $569,499	14,114 Added 36.25%	53,052 $1.9 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $17,654 - $21,055	534 Added 1.39%	38,938 $1.54 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $353,961 - $457,770	11,496 Added 42.72%	38,404 $1.39 Million
Q2 2022 Aug 12, 2022	SELL	$25.44 - $35.16 $49,048 - $67,788	-1,928 Reduced 6.69%	26,908 $818,000
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $19,419 - $25,642	774 Added 2.76%	28,836 $881,000
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $437,767 - $993,394	28,062 New	28,062 $876,000
Q3 2021 Nov 15, 2021	SELL	$14.86 - $19.45 $4.74 Million - $6.21 Million	-319,090 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$16.81 - $20.0 $263,093 - $313,020	-15,651 Reduced 4.68%	319,090 $5.94 Million
Q1 2021 May 14, 2021	SELL	$13.65 - $21.31 $42,178 - $65,847	-3,090 Reduced 0.91%	334,741 $5.99 Million
Q4 2020 Mar 01, 2021	SELL	$9.49 - $16.04 $288,951 - $488,385	-30,448 Reduced 8.27%	337,831 $5.2 Million
Q3 2020 Nov 13, 2020	BUY	$10.82 - $13.35 $38,108 - $47,018	3,522 Added 0.97%	368,279 $4.08 Million
Q2 2020 Aug 14, 2020	BUY	$10.21 - $14.9 $3.72 Million - $5.43 Million	364,757 New	364,757 $4.57 Million

Others Institutions Holding XENE

# of Institutions

219

Shares Held

70.3M

Call Options Held

444K

Put Options Held

207K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $1.92B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Xenon Pharmaceuticals Inc. Transaction History